Clinical trialNCT05090748CompletedObservational

Study for the Assessment of the Quality of Echocardiographic Clips.

SponsorUltraSightEnrollment240Cardiac Disease

View the registry record on ClinicalTrials.gov

Summary

The lay summary the sponsor registered on ClinicalTrials.gov.

This study main objective is to evaluate the safety and efficacy of the UltraSight AI Guidance software. The investigational product is a software that guides the user to capture a high quality ultrasound image. The study will include healthcare professionals, not specialized in echocardiography, who will perform echocardiography by using UltraSight AI Guidance software, on subjects in the medical centers cardiac units.

clinicaltrials.gov ↗

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

Bijoy Khandheria, MD
Aurora Saint Luke Medical Center
Principal Investigator
clinicaltrials.gov ↗
Danny Spigelstein, MD
UltraSight
Study Director
clinicaltrials.gov ↗
Federico Asch, MD
Medstar Health Research Institute
Principal Investigator
clinicaltrials.gov ↗
Praveen Mehrotra, MD
Thomas Jefferson University
Principal Investigator
clinicaltrials.gov ↗
Robert Klampfner, MD
Sheba Medical Center
Principal Investigator
clinicaltrials.gov ↗
Roberto Lang, MD
U of Chicago
Principal Investigator
clinicaltrials.gov ↗

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

3 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

Israel

Sheba Mc
Ramat Gan, Israel

United States

University of Chicago Medicine
Chicago, Illinois, United States
Aurora St. Luke'S Medical Center
Milwaukee, Wisconsin, United States

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study. It may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start: 15 May 2022
Primary completion: 5 Aug 2022
Completion: 31 Aug 2022
Last update posted: 7 Dec 2022
Registered enrollment: 240
Registry id: NCT05090748

clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.